List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #20,921 to #20,970.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. FACSM → Fellow of the American College of Sports Medicine
  2. FACT → Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
  3. FAC regimen → CAF regimen
  4. FADH → Flavin
  5. FAH gene → Fumarylacetoacetate hydrolase
  6. FALS → Amyotrophic lateral sclerosis
  7. FAMIS → Fosinopril In Acute Myocardial Infarction Study
  8. FANCC gene → Fanconi anemia, complementation group C
  9. FANCG gene → FANCG
  10. FANTASTIC → Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
  11. FAO → Food and Agriculture Organization
  12. FAST → Femoral Artery Stenting Trial
  13. FAST-MAG → Field Administration Of Stroke Therapy - Magnesium
  14. FASTER → Fibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
  15. FAS ligand → Fas ligand
  16. FATS → Familial Atherosclerosis Treatment Study (FATS)
  17. FATS Trial → Familial Atherosclerosis Treatment Study (FATS)
  18. FATS trial → Familial Atherosclerosis Treatment Study (FATS)
  19. FAVA → Provisionally unclassified vascular anomalies#Fibro adipose vascular anomaly (FAVA)
  20. FBG → Blood sugar
  21. FBS → Blood sugar
  22. FCM-R regimen → FMC-R regimen
  23. FCMR Regimen → FMC-R regimen
  24. FCM regimen → FMC regimen
  25. FD&C → Federal Food, Drug, and Cosmetic Act
  26. FDA → Food and Drug Administration
  27. FDA Advisors Under Review for the Potential of Financial Conflict. August 8, 2007 → Special:Badtitle/NS100:FDA Advisors Under Review for the Potential of Financial Conflict
  28. FDA Panel Recommends Approval of New DES → Special:Badtitle/NS100:FDA Panel Recommends Approval of New DES
  29. FDA Panel Review of Ticagrelor on July 28th, 2010 → FDA panel review of ticagrelor on July 28th, 2010
  30. FDA Requires Stronger Heart Failure Warning for Avandia and Actos → Special:Badtitle/NS100:FDA Requires Stronger Heart Failure Warning for Avandia and Actos
  31. FDG → Fluorodeoxyglucose
  32. FDG-PET → Positron emission tomography
  33. FDP → Fibrin degradation product
  34. FEES → Flexible fiberoptic endoscopic examination of swallowing
  35. FEMINA → Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
  36. FEMSEPT → Estradiol
  37. FENIB → Familial encephalopathy with neuroserpin inclusion bodies
  38. FENa → Fractional sodium excretion
  39. FERRIC-HF → Effect Of Intravenous Ferrous Sucrose On Exercise Capacity In Chronic Heart Failure
  40. FES → Fat embolism syndrome
  41. FEST → Fosinopril Efficacy/Safety Trial
  42. FEUA → Fractional excretion of uric acid
  43. FEV1 → Spirometry
  44. FE C Tab Plus → Iron
  45. FFA → Fatty acid#Free fatty acids
  46. FFP → Fresh frozen plasma
  47. FFR → Fractional flow reserve
  48. FFR-guided PCI Reduces Incidence of Clinical Events in Patients with Multi-Vessel Disease: Results of the FAME Study → Special:Badtitle/NS100:FFR-guided PCI Reduces Incidence of Clinical Events in Patients with Multi-Vessel Disease: Results of the FAME Study
  49. FGF-23 → Fibroblast growth factor 23
  50. FGF2 → Basic fibroblast growth factor

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"